Stelios Papadopoulos - Net Worth and Insider Trading
Stelios Papadopoulos Net Worth
The estimated net worth of Stelios Papadopoulos is at least $34 Million dollars as of 2024-03-19. Stelios Papadopoulos is the Director of Exelixis Inc and owns about 1,220,036 shares of Exelixis Inc (EXEL) stock worth over $28 Million. Stelios Papadopoulos is the Director of Biogen Inc and owns about 26,580 shares of Biogen Inc (BIIB) stock worth over $6 Million. Stelios Papadopoulos is also the Director of Regulus Therapeutics Inc and owns about 118,987 shares of Regulus Therapeutics Inc (RGLS) stock worth over $280,809. Details can be seen in Stelios Papadopoulos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stelios Papadopoulos has not made any transactions after 2022-02-22 and currently still holds the listed stock(s).
Transaction Summary of Stelios Papadopoulos
Stelios Papadopoulos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stelios Papadopoulos owns 7 companies in total, including Regulus Therapeutics Inc () , Biogen Inc () , and Exelixis Inc () among others .
Click here to see the complete history of Stelios Papadopoulos’s form 4 insider trades.
Insider Ownership Summary of Stelios Papadopoulos
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Regulus Therapeutics Inc | 2019-05-07 | director | |
Biogen Inc | 2015-07-27 | director | |
Exelixis Inc | 2022-02-22 | director | |
BG Medicine Inc | 2015-11-18 | director | |
Genvec Inc | 2006-06-22 | director | |
Eucrates Biomedical Acquisition Corp | 2020-10-23 | director & 10 percent owner | |
Eucrates Biomedical Acquisition Corp | 2020-10-23 | director & 10 percent owner |
Stelios Papadopoulos Latest Holdings Summary
Stelios Papadopoulos currently owns a total of 3 stocks. Among these stocks, Stelios Papadopoulos owns 1,220,036 shares of Exelixis Inc (EXEL) as of February 22, 2022, with a value of $28 Million and a weighting of 82.22%. Stelios Papadopoulos owns 26,580 shares of Biogen Inc (BIIB) as of July 27, 2015, with a value of $6 Million and a weighting of 16.96%. Stelios Papadopoulos also owns 118,987 shares of Regulus Therapeutics Inc (RGLS) as of May 7, 2019, with a value of $280,809 and a weighting of 0.82%.
Latest Holdings of Stelios Papadopoulos
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EXEL | Exelixis Inc | 2022-02-22 | 1,220,036 | 23.17 | 28,268,234 |
BIIB | Biogen Inc | 2015-07-27 | 26,580 | 219.40 | 5,831,652 |
RGLS | Regulus Therapeutics Inc | 2019-05-07 | 118,987 | 2.36 | 280,809 |
Holding Weightings of Stelios Papadopoulos
Stelios Papadopoulos Form 4 Trading Tracker
According to the SEC Form 4 filings, Stelios Papadopoulos has made a total of 3 transactions in Exelixis Inc (EXEL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Exelixis Inc is the sale of 84,515 shares on February 22, 2022, which brought Stelios Papadopoulos around $2 Million.
According to the SEC Form 4 filings, Stelios Papadopoulos has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the acquisition of 10,000 shares on July 27, 2015, which cost Stelios Papadopoulos around $3 Million.
According to the SEC Form 4 filings, Stelios Papadopoulos has made a total of 1 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 37,037 shares on May 7, 2019, which cost Stelios Papadopoulos around $400,000.
Insider Trading History of Stelios Papadopoulos
- 1
Stelios Papadopoulos Trading Performance
GuruFocus tracks the stock performance after each of Stelios Papadopoulos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stelios Papadopoulos is 3.37%. GuruFocus also compares Stelios Papadopoulos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stelios Papadopoulos within 3 months outperforms 3 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stelios Papadopoulos's insider trading performs compared to the benchmark.
Performance of Stelios Papadopoulos
Average Relative Return
-9.5%
Outperforming Transactions
22%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | -2.21 | 3.37 | 33.85 | -9.5 | -15.88 | -24.16 |
Relative Return to S&P 500(%) | -2.87 | -0.49 | 25.43 | -23.63 | -31.07 | -38.32 |
Stelios Papadopoulos Ownership Network
Ownership Network List of Stelios Papadopoulos
Ownership Network Relation of Stelios Papadopoulos
Stelios Papadopoulos Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Stelios Papadopoulos is the director of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .
Regulus Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Stelios Papadopoulos made no insider transaction in Regulus Therapeutics Inc (). Other recent insider transactions involving Regulus Therapeutics Inc () include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .
In summary, during the past 3 months, insiders sold 25,516 shares of Regulus Therapeutics Inc () in total and bought 0 shares, with a net sale of 25,516 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.
Regulus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Stelios Papadopoulos Mailing Address
Above is the net worth, insider trading, and ownership report for Stelios Papadopoulos. You might contact Stelios Papadopoulos via mailing address: 3 Somerset Drive South, Great Neck Ny 11020.